Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| SO1-H5148 | Human | Human SOD1 / Cu-Zn SOD Protein, His Tag (active enzyme) |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Orgotein | Approved | Gt Biopharma Inc | Ontosein | Spain | Rheumatic Diseases; Cystitis; Radiation Injuries | null | 1996-01-01 | Cystitis; Radiation Injuries; Rheumatic Diseases | Details | |
| Cupric Sulfate/Manganese sulfate/Selenious acid/Zinc Sulfate | Approved | American Regent Inc | MULTRYS | United States | Dietary Supplement | American Regent Inc | 2020-07-02 | Dietary Supplement | Details | |
| Tofersen | 99mTc-MAG3-BIIB067; ISIS-333611; BIIB-067; SODr/h333611; ISIS-SOD1Rx; IONIS SOD1Rx | Approved | Ionis Pharmaceuticals Inc, Ludwig Institute For Cancer Research | QALSODY, Qalsody, 凯盛迪 | United States | Amyotrophic Lateral Sclerosis | Biogen Ma Inc, Biogen Inc | 2023-04-25 | Familial Amyotrophic Lateral Sclerosis; Amyotrophic Lateral Sclerosis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Otaplimastat | SP-8203 hydrochloride; SP8203 HCL; SP-8203 | Phase 3 Clinical | Shin Poong Pharmaceutical Co Ltd | Ischemic Stroke | Details |
| Superoxide dismutase (Ube Industries) | r-hSOD; FKU-871 | Phase 2 Clinical | Ube Industries Ltd, Astellas Pharma Inc | Myocardial Ischemia; Diabetic Neuropathies | Details |
| BMX-010 | BMX-010; MnTE-2-PyP; MnTE-2-PyP5+ | Phase 2 Clinical | Duke University | Acne Vulgaris; Rosacea; Psoriasis; Dermatitis, Atopic | Details |
| APB-102 | APB-102; AMT-162 | Phase 2 Clinical | University Of Massachusetts Medical School | Amyotrophic Lateral Sclerosis | Details |
| Rucosopasem manganese | GC-4711 | Phase 1 Clinical | Galera Therapeutics Inc | Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Bis-choline tetrathiomolybdate | WTX-101; ALXN-1840; ATN-224 | Phase 1 Clinical | Wilson Therapeutics | Hepatolenticular Degeneration; Multiple Myeloma; Prostatic Neoplasms; Melanoma | Details |
| NAS150 | AEOL-10150; NAS150; NAS-150 | Phase 1 Clinical | Aeolus Pharmaceuticals | Supranuclear Palsy, Progressive; Idiopathic Pulmonary Fibrosis; Neoplasms; Lung Injury | Details |
| RAG-17 | RAG-17; RAG17 | Phase 1 Clinical | Sino-Us Institute Of Rna Technology | Amyotrophic Lateral Sclerosis | Details |
| ALN-SOD | ALN-SOD | Phase 1 Clinical | Alnylam Pharmaceuticals Inc | Amyotrophic Lateral Sclerosis | Details |
This web search service is supported by Google Inc.
A-Z
